Skip to content

Comparison of the effects of misoprostol and oxytocine on postpartum Hemorrhage

Comparison of the effects of misoprostol and oxytocine on postpartum Hemorrhage

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100429003833N2
Enrollment
237
Registered
2021-10-02
Start date
2021-10-23
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum hemorrhage. Other immediate postpartum haemorrhage

Interventions

Intervention 1: Intervention group 1: Oxytocin 10 units (inside 500 cc of Ringer's serum) and sublingual misoprostol tablets of 400 micrograms (after placental abruption and uterine correction are ins

Sponsors

Vice chancellor for Research,Tabriz University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: singleton pregnant women elective cesarean delivery Maximum history of once cesarean section

Exclusion criteria

Exclusion criteria: Preeclampsia Cardiovascular diseases Uterine myoma A history of excessive bleeding after delivery. Underlying disease, such as coagulopathy Abnormal placental implantation (Placenta peria or Ecrta)

Design outcomes

Secondary

MeasureTime frame
Drug side effects. Timepoint: From the time of hospitalization to the patient's discharge. Method of measurement: Control vital signs.

Primary

MeasureTime frame
Bleeding volume during cesarean section. Timepoint: After the placenta is removed until the uterus is repaired. Method of measurement: Number of gases and lumps of wet gases and volume of blood in suction.;Bleeding volume during the first 24 hours of cesarean section. Timepoint: Hemoglobin and hematocrit are measured 24 hours after surgery and compared with preoperative values. Method of measurement: blood test.;Duration of surgery. Timepoint: From the start of surgery to complete repair of the uterus. Method of measurement: Record start and end times.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahideh Rahmani

Tabriz University of Medical Sciences

lahroudin@gmail.com+98 35519161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026